Ketone bodies mediate antiseizure effects through mitochondrial permeability transition.
Ketone bodies mediate antiseizure effects through mitochondrial permeability transition.
复制标题
酮体通过线粒体渗透性过渡介导抗性作用。
DOI:
10.1002/ana.24424
复制
发表时间:
2015-07
影响因子:
11.2
通讯作者:
Rho, Jong M.
中科院分区:
文献类型:
--
作者:
Kim, Do Young;Simeone, Kristina A.;Simeone, Timothy A.;Pandya, Jignesh D.;Wilke, Julianne C.;Ahn, Younghee;Geddes, James W.;Sullivan, Patrick G.;Rho, Jong M.
Ketone bodies (KB) are products of fatty acid oxidation and serve as essential fuels during fasting or treatment with the high-fat anti-seizure ketogenic diet (KD). Despite growing evidence that KB exert broad neuroprotective effects, their role in seizure control has not been firmly demonstrated. The major goal of this study was to demonstrate the direct anti-seizure effects of KB and to identify an underlying target mechanism. We studied the effects of both the KD and KB in spontaneously epileptic Kcna1-null mice using a combination of behavioral, planar multi-electrode, and standard cellular electophysiological techniques. Thresholds for mitochondrial permeability transition (mPT) were determined in acutely isolated brain mitochondria. KB alone were sufficient to: (1) exert anti-seizure effects in Kcna1-null mice; (2) restore intrinsic impairment of hippocampal long-term potentiation (LTP) and spatial learning-memory defects in Kcna1-null mutants; and (3) raise the threshold for calcium-induced mPT in acutely prepared mitochondria from hippocampi of Kcna1-null animals. Targeted deletion of the cyclophilin D (CypD) subunit of the mPT complex abrogated the effects of KB on mPT, and in vivo pharmacological inhibition and activation of mPT were found to mirror and reverse, respectively, the anti-seizure effects of the KD in Kcna1-null mice. The present data reveal the first direct link between mPT and seizure control, and provide a potential mechanistic explanation for the KD. Given that mPT is increasingly being implicated in diverse neurological disorders, our results suggest that metabolism-based treatments and/or metabolic substrates might represent a worthy paradigm for therapeutic development.
登录
查看更多内容
影响因子:
4.2
作者:
Davis, Laurie M.;Pauly, James R.;Sullivan, Patrick G.
通讯作者:
Sullivan, Patrick G.
影响因子:
4
作者:
Kovac S;Domijan AM;Walker MC;Abramov AY
通讯作者:
Abramov AY
DOI:
10.1097/mco.0b013e3282f44c06
发表时间:
2008-03-01
影响因子:
3.1
作者:
Kim, Do Young;Rho, Jong M.
通讯作者:
Rho, Jong M.
影响因子:
4.8
作者:
Jiang, DM;Sullivan, PG;Weiss, JH
通讯作者:
Weiss, JH
影响因子:
2.2
作者:
Cock, HR;Tong, X;Walker, MC
通讯作者:
Walker, MC